Collector
Giriş Yap
Novo Nordisk faces off in court with South African weight-loss drug compounder | Collector
Novo Nordisk faces off in court with South African weight-loss drug compounder

Novo Nordisk faces off in court with South African weight-loss drug compounder

Danish drugmaker Novo Nordisk NOVOb.CO is heading to court in South Africa on Wednesday to try to halt the sale of unapproved copies of semaglutide, the key ingredient in its blockbuster weight-loss and diabetes drugs Wegovy and Ozempic.

Go to News Site